|
| Tissue | Model/condition | Effect | Reference |
|
| Erythrocytes | Obese type 2 diabetic patients | ↑ | [46] |
| Erythrocytes | Type 2 diabetic patients versus healthy subjects | ↑ | [47] |
| Erythrocyte membrane | Type 2 diabetic patients versus healthy subjects | ↑ | [48] |
| Lymphocytes | Type 2 diabetic patients versus age-matched controls | ↑ | [49] |
| Lymphocytes | DM patients versus healthy subjects | ↑ | [50] |
| Placenta | Women with gestational diabetes versus healthy pregnant women | ↑ | [51] |
| Plasma proteins | Type 2 diabetic patients versus healthy subjects | = | [52] |
| Plasma proteins | Dialysis patients versus control subjects | ↑ | [53] |
| Plasma proteins | Diabetic type 2 patients versus healthy subjects | ↑ | [54] |
| Plasma proteins | Type 1 diabetes without complications | ↑ | [55] |
| Plasma proteins | Type 1 diabetes with complications | ↑ | [55] |
| Plasma proteins | Chronic kidney disease patients versus healthy subjects | ↑ | [56] |
| Plasma proteins | Diabetes type 2 versus healthy subjects | ↑ | [57] |
| Plasma proteins | Diabetes type 2 associated with CVD versus healthy subjects | ↑ | [57] |
| Plasma proteins | Good glycemic control versus poor glycemic control | ↑ | [58] |
| Plasma proteins | Type 1 diabetic patients | = | [59] |
| Plasma proteins | End-stage renal disease | ↑ | [59] |
| Plasma proteins | Heart failure + diabetes versus healthy subjects | ↑ | [60] |
| Plasma proteins | Type 2 diabetes without microangiopathy versus healthy subjects | ↑ | [61] |
| Plasma proteins | Type 2 diabetes with microangiopathy versus healthy subjects | ↑ | [61] |
| Plasma proteins | Type 2 diabetic patients versus age-matched controls | ↑ | [49] |
| Plasma proteins | Childhood type 1 diabetes | ↑ | [62] |
| Plasma proteins | Diabetic patients without ulcer versus healthy subjects | ↑ | [63] |
| Plasma proteins | Diabetic patients with foot ulcer grade 1 versus healthy subjects | ↑ | [63] |
| Plasma proteins | Diabetic patients with foot ulcer grade 2 versus healthy subjects | ↑ | [63] |
| Plasma proteins | Diabetic patients versus healthy subjects | ↑ | [64] |
| Plasma proteins | IGT subjects versus healthy subjects | ↑ | [64] |
| Plasma proteins | Diabetic type 2 patients versus healthy subjects | ↑ | [65] |
| Platelets | Type 2 diabetes (young versus elderly) | ↑ | [66] |
| Serum | Type 1 diabetic patients versus healthy subjects | ↑ | [67] |
| Serum | Diabetic patients versus healthy subjects | ↑ | [68] |
| Serum | Diabetic nephropathy patients versus healthy subjects | ↑ | [68] |
| Skin collagen | Type 2 diabetes | ↑ | [69] |
| Subretinal fluid | Diabetic patients versus control subjects | ↑ | [70] |
|
